Todos Medical wants to follow in the competition's footsteps in developing and promoting its blood-based colorectal cancer test, CEO Herman Weiss, MD, said in an update on the state of the company at a conference in Los Angeles.
What you should know:
1. Todos is developing TM-C1, a blood-based diagnostic test for colon cancer.
2. Todos is in the midst of studying TM-C1.
3. When elaborating on the next steps for TM-C1, Dr. Weiss referenced Exact Sciences' developmental path.
"Exact Sciences has shown successful adoption for their colon cancer stool test and we believe we can replicate their roadmap to success with a simple blood test," Dr. Weiss said.
4. The company has blood-based tests for breast and other cancers in development.